Stay updated on Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.

Latest updates to the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page
- ChecktodayChange DetectedA References section has been added to the study record history, providing citations and sources for the study updates. This addition helps users locate supporting materials linked to prior submissions.SummaryDifference0.1%

- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedFooter revision updated from v3.6.4 to v3.6.5, indicating a minor site software release. This update does not modify any study data or the history records displayed on the page.SummaryDifference0.0%

- Check22 days agoChange DetectedAdded a new version entry on 2026-07-31 with a Study Status note linked to 2026-07-30 and the value 90. Removed the 2026-07-13 entry from the history.SummaryDifference0.2%

- Check29 days agoChange DetectedThe page's revision label in the footer was updated to v3.6.4, replacing the previous v3.6.3 to reflect a new deployment.SummaryDifference0.0%

- Check36 days agoChange DetectedA new version entry (89) appears around 2026-07-10/13, adding the 'Study Status' and 'Study Identification' sections, and the 2026-06-05 entry was deleted.SummaryDifference0.2%

- Check51 days agoChange DetectedThe footer now displays Revision: v3.6.3, replacing v3.6.2, indicating a new site release was deployed.SummaryDifference0.0%

Stay in the know with updates to Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Teclistamab Dose Escalation Study in Multiple Myeloma Clinical Trial page.